Skip to content

Released Mar 10, 2016, after the close

10-K filed Mar 10, 2016, 70 days after period end · 0001144204-16-087232

Q4 2015 · 10-K
Revenue—
Net Income-$4.63MN/M vs Q4 2014N/M vs Q3 2015
EPS Diluted-$0.25no prior Q4 2014 on fileN/M vs Q3 2015
Operating Income-$4,696,098N/M
Operating Cash Flowderived-$2,911,627N/M
Free Cash Flowderived-$2,911,626N/M

What the release said

The release

Same quarter

MetricQ4 2015Q4 2014derived from reported figuresQ4 2013derived from reported figuresQ4 2012derived from reported figures
Net Income-$4.63M-$4.04M-$4.39M$5.02M
EPS Diluted-$0.25———

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR